Royalty Pharma Plc · NASDAQ:RPRX
Coyne Terrance P. sold 11,002 Royalty Pharma Plc shares (Form 4)
Traded Aug 13, 2026 · Filed Aug 17, 2026
On Aug 13, 2026, Coyne Terrance P. (EVP & CFO) sold 11,002 Royalty Pharma Plc shares at an average US$58.68 for US$646K under a trading plan, leaving 0 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 11,002 shares
- Price
- US$58.68 average (US$58.59 to US$59.14)
- Value
- US$646K
- Holding after
- 0 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP & CFO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Class A Ordinary Shares | Sale | 9,230 | US$58.59 | 1,772 | Indirect |
| Aug 13, 2026 | Class A Ordinary Shares | Sale | 1,772 | US$59.14 | 0 | Indirect |
Source
Related
- Royalty Pharma Plc
- Coyne Terrance P.
- Royalty Pharma Plc shareholders
- Form 4 · Coyne Terrance P. · Aug 7, 2026
- Form 4 · Coyne Terrance P. · May 28, 2026
- Form 4 · Coyne Terrance P. · May 8, 2026
- Form 4 · Coyne Terrance P. · Apr 30, 2026
- Form 4 · Coyne Terrance P. · Apr 2, 2026
- Form 4 · Urist Marshall · Oct 5, 2026
- Form 4 · Bassler Bonnie L · Sep 30, 2026
- Form 4 · Urist Marshall · Sep 30, 2026
- Form 4 · Hite Christopher · Sep 24, 2026
- Form 4 · Hite Christopher · Aug 19, 2026